Peptides and Non Peptides of Oncologic and Neuroendocrine Relevance
From Basic to Clinical Research
Versandkostenfrei!
Versandfertig in 1-2 Wochen
115,99 €
inkl. MwSt.
Weitere Ausgaben:
PAYBACK Punkte
58 °P sammeln!
The book describes the ability of a series of endocrine-derived compounds,
i.e. CHRH, LHRH, somatostatin, anti-androgens, and aromatase inhibitors to
exert a direct anti-neoplastic activity or to potentiate the activity of
traditional chemotherapeutic agents on neuroendocrine and solid tumors. In
addition, a new class of potent GH-releasers, GSHs/Ghrelin, endowed with
important endocrine and extra-endcocrine action, is presented. Therefore,
in addition to traditional chemotherapy, characterized by high toxicity and
non-selective action on tumoral cells, the reader can find a new approach
with more selective, less cytotoxic endocrine derived compounds TOC:
i.e. CHRH, LHRH, somatostatin, anti-androgens, and aromatase inhibitors to
exert a direct anti-neoplastic activity or to potentiate the activity of
traditional chemotherapeutic agents on neuroendocrine and solid tumors. In
addition, a new class of potent GH-releasers, GSHs/Ghrelin, endowed with
important endocrine and extra-endcocrine action, is presented. Therefore,
in addition to traditional chemotherapy, characterized by high toxicity and
non-selective action on tumoral cells, the reader can find a new approach
with more selective, less cytotoxic endocrine derived compounds TOC:
Andere Kunden interessierten sich für
